- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 583
Frichti cooks up $13.6m series A
Meal delivery service Frichti has added Idinvest, the private equity firm backed by corporates including Allianz, to its shareholders.
Mar 31, 2016Shell Technology Ventures transmits cash to VC funds
The corporate venturing unit has become a limited partner in energy-focused venture capital funds GRC SinoGreen Fund III and Set Ventures.
Mar 30, 2016Skoltech's new president reveals plans
Alexander Kuleshov talks about his role as the president of Skolkovo Institute of Science and Technology (Skoltech), created in collaboration with MIT.
Mar 30, 2016Imperial Innovations to lose Knight
Imperial Innovations chairman Martin Knight is to stand down from his role at the end of July following 13 years at the firm.
Mar 30, 2016Utrecht latches on to Baxalta for $7.9m series A
Utrecht Holdings participated in a round that will support the cancer immunotherapy spinout as it looks to advance a leukaemia candidate into clinical testing.
Mar 30, 2016Gadeta latches on to Baxalta for $7.9m series A
Baxalta's corporate venturing vehicle co-led a round that will support the cancer immunotherapy developer as it looks to advance a leukaemia candidate into clinical testing.
Mar 30, 2016Sphere Fluidics rounds off $7m
The Cambridge spinout previously raised a $2.5m series A round backed by the university and up to $3.4m in a 2014 funding round backed by Parkwalk Advisors.
Mar 30, 2016Neuroloop circles big investment
The Freiburg spinout has secured an undisclosed amount from Aesculap that is said to be one of the largest corporate venturing investments in a German spinout to date.
Mar 30, 2016Hyper visualises acquisition
Tableau Software has acquired Technical University of Munich spinout Hyper, a data visualisation technology developer.
Mar 29, 2016Maat Pharma balances out series A with $11m
Biocodex led the round, which will fund the start of clinical studies for Maat's microbiome-based dysbiosis treatment this summer.
Mar 29, 2016About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


